Bozena Szygula-Jurkiewicz
Overview
Explore the profile of Bozena Szygula-Jurkiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jurkiewicz M, Szczurek-Wasilewicz W, Skrzypek M, Krych S, Gasior M, Szygula-Jurkiewicz B
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941479
: Risk stratification in elderly patients with heart failure (HF) is very difficult. There is a lack of reliable tools for assessing the risk of death in this population of...
2.
Nadziakiewicz P, Szczurek-Wasilewicz W, Szygula-Jurkiewicz B
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861095
Heart failure (HF) is a common condition and one of the main morbidity and mortality factors in elderly patients. The incidence of HF progressively increases with age, reaching >10% in...
3.
Szczurek-Wasilewicz W, Jurkiewicz M, Skrzypek M, Romuk E, Jozwiak J, Gasior M, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796029
Biomarkers are critical for heart failure (HF) management by facilitating risk stratification, therapeutic decision-making, and monitoring treatment response. This prospective, single-center study aimed to assess predictors of death during one-year...
4.
Smyla-Gruca W, Szczurek-Wasilewicz W, Skrzypek M, Romuk E, Karmanski A, Jurkiewicz M, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200231
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species and cells' ability to neutralize them by antioxidant systems. The role of oxidative stress in hypertrophic cardiomyopathy...
5.
Nadziakiewicz P, Szygula-Jurkiewicz B
Kardiochir Torakochirurgia Pol
. 2024 Jul;
21(2):102-107.
PMID: 39055247
Patients with cancer are prone to develop pulmonary embolism (PE) in the course of cancer-associated thrombosis. These patients have increased risk of both recurrent venous thromboembolism and major bleeding. Pulmonary...
6.
Szczurek-Wasilewicz W, Warmusz O, Skrzypek M, Karmanski A, Jurkiewicz M, Wyrobiec P, et al.
Kardiol Pol
. 2024 Jun;
82(7-8):741-748.
PMID: 38845423
Background: Growth differentiation factor-15 (GDF-15) is a hormone that regulates inflammatory responses, tissue repair, and cardiac remodeling, the three key processes underlying the development and progression of heart failure (HF)....
7.
Szczurek-Wasilewicz W, Skrzypek M, Karmanski A, Jurkiewicz M, Gasior M, Szygula-Jurkiewicz B
Pol Arch Intern Med
. 2024 May;
134(7-8).
PMID: 38804895
Introduction: Accurate risk assessment in patients with heart failure (HF) is crucial. Developing new models that combine biochemical and clinical variables with novel biomarkers is the best approach to improving...
8.
Smyla-Gruca W, Szczurek-Wasilewicz W, Skrzypek M, Karmanski A, Romuk E, Jurkiewicz M, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540275
The role of oxidative/antioxidative system imbalances in advanced heart failure (HF) has not been fully investigated. The aim of this study was to identify factors associated with one-year mortality in...
9.
Niedziela J, Rozentryt P, Nowak J, Szygula-Jurkiewicz B, Pyka L, Ciesla D, et al.
Kardiol Pol
. 2024 Mar;
82(4):391-397.
PMID: 38493451
Background: There are no data on the characteristics and outcomes for patients with heart failure (HF) with reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) ejection fraction diagnosed according to...
10.
Szczurek-Wasilewicz W, Hawranek M, Skrzypek M, Hrapkowicz T, Gasior M, Warmusz O, et al.
Postepy Kardiol Interwencyjnej
. 2023 Feb;
18(3):237-245.
PMID: 36751283
Introduction: Cardiac allograft vasculopathy (CAV) is a major threat to long-term survival after heart transplantation (HT). Aim: To determine factors associated with CAV detection in patients after HT. Material And...